Anders H. Lund
Administrerende Direktør
BRIC Administration
Ole Maaløes Vej 5, 2200 København N.
ORCID: 0000-0002-7407-3398
Scientific focus areas
- Cancer biology with emphasis on senescence and translational control
- Non-coding RNA
- Ribosome biology
Education and occupation
- Director, BRIC, University of Copenhagen, Denmark, 2019 –
- Director (interim), BRIC, University of Copenhagen, Denmark, 2018 – 2019
- Professor, BRIC, University of Copenhagen, Denmark, 2009 -
- Associate professor, BRIC, University of Copenhagen, Denmark, 2004-2009.
- Post-doc, The Netherlands Cancer Institute, Amsterdam, 1999-2004.
- Post-doc, Department of Molecular and Structural Biology, University of Aarhus, 1996-1999.
- PhD., Molecular Biology, University of Aarhus, 1996.
- Cand. scient., Biology, University of Aarhus, 1993.
Honors and Awards
- Elected to The Royal Danish Academy of Sciences and Letters, 2018
Personal stipends
- Distinguished Investigator, The Novo Nordisk Foundation, 2018-2023.
- Sapere Aude Topforsker, DFF Advanced Grant, 2015-2019.
- Hallas-Møller Stipendium, Novo Nordisk Fonden, 2009-2014.
- Vilhelm Pedersen og Hustrus Seniorforskerstipendium, 2004-2009.
- Postdoc stipendium (FSS), 1999-2002.
Research management
- Head of independent research laboratory, 2004-
- Director (interim), Biotech Research and Innovation Centre, University of Copenhagen, 2018-
- Coordinator, The International Doctoral Programme in Molecular Mechanisms of Disease (iMED), H2020 MSCA COFUND, 2018-2023.
- Coordinator, The Lundbeck Foundation. “Caught in translation - targeting disease ribosomes” (€1.3M), 2015-2019.
- Director (founding) of the PhD Career Program (PCAP), Faculty of Health and Medical Sciences, University of Copenhagen 2014-2017.
- Director of the PhD Graduate Program Molecular Mechanisms of Disease 2011-2017.
- Scientific Coordinator of the research education program Molecular Mechanisms of Disease 2006 – 2010.
- Coordinator, ITN Marie Curie EU-FP7 network, ”RNATRAIN”, (€3.5M), 2013-2017.
- Project coordinator: “Novel medicines for treatment of cancer and neurological disorders”. High technology platform (€6M), the Danish National Advanced Technology Foundation, 2008 - 2012.
- Board member, Danish Cancer Research Foundation 2011 – 2016
- Board member, The Scientific Committee of the Danish Cancer Society 2013 - 2018
Scientific Advisory Board, Immagina Biotechnology, 2023 -
Uddannelse
cand. scient, biologi, Aarhus Universitet, PhD, molekylærbiologi, Aarhus Universitet
ID: 11878
Flest downloads
-
3431
downloads
microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
3015
downloads
microRNA-143 down-regulates Hexokinase 2 in colon cancer cells
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet -
2950
downloads
Loss of miR-10a activates Lpo and collaborates with activated Wnt signaling in inducing intestinal Neoplasia in female mice
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet